Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function

PURPOSE: The Phase 3 LIBERTY ASTHMA QUEST study in patients aged ≥12 years with uncontrolled, moderate-to-severe asthma demonstrated the efficacy and safety of dupilumab 200 mg and 300 mg every 2 weeks (q2w) vs matched placebo in the overall population. This post hoc analysis assessed dupilumab effi...

Full description

Saved in:

Bibliographic Details
Published in:	J Asthma Allergy
Main Authors:	Pavord, Ian D, Siddiqui, Salman, Papi, Alberto, Corren, Jonathan, Sher, Lawrence D, Bardin, Philip, Langton, David, Park, Hae-Sim, Rice, Megan S, Deniz, Yamo, Rowe, Paul, Staudinger, Heribert W, Patel, Naimish, Ruddy, Marcella, Graham, Neil M H, Teper, Ariel
Format:	Artigo
Language:	Inglês
Published:	Dove 2020
Subjects:	Original Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7751293/ https://ncbi.nlm.nih.gov/pubmed/33364789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S275068
Tags:	Add Tag No Tags, Be the first to tag this record!

Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function

Similar Items